Thrombin Stimulated Platelet-Derived Exosomes Inhibit Platelet-Derived Growth Factor Receptor-Beta Expression in Vascular Smooth Muscle Cells

Background/Aims: It is difficult to predict acute thrombotic cardiovascular events in the clinic. Few studies have reported the presence of plasma exosomes containing microRNAs (miRNAs) in cardiovascular events. Therefore, we aimed to investigate the levels of miR-223, miR-339 and miR-21 in plasma exosomes before thrombosis in mouse models of carotid tandem stenosis, as well as the mechanisms underlying the origin and function of these exosomal miRNAs. Methods: Plasma samples were collected from the carotid tandem stenosis and sham control groups of our successfully developed atherothrombosis mouse models before thrombosis. Platelets from healthy volunteers and mice were purified to obtain thrombin stimulated platelet-derived exosomes. Exosomes were isolated via differential ultracentrifugation, and western blotting and transmission electron microscopy were used for their identification. The total RNA was extracted, and quantitative real-time PCR was performed to determine the expression levels of miR-223, miR-339 and miR-21. DAVID Tools were used to analyze the pathways that were enriched among the miRNA target genes. Immuno-fluorescence staining was performed to identify the protein expression levels of platelet-derived exosome target genes in vascular smooth muscle cells (SMCs) in vitro and in vivo. Results: The levels of miR-223, miR-339 and miR-21, which are associated with platelet activation, were elevated in pooled mouse plasma exosomes before thrombosis and enriched in thrombin-stimulated platelet-derived exosomes in vitro. Platelet-derived growth factor receptor-beta (PDGFRβ) was a target of these miRNAs, and PDGFRβ expression in vascular smooth muscle cells (SMCs) was inhibited following incubation with platelet-derived exosomes. Platelet-derived exosomes could also inhibit PDGF-stimulated SMC proliferation. Furthermore, a decrease in PDGFRβ expression was observed in vascular SMCs around thrombotic areas in vivo. Conclusions: Our data indicate that activated platelet-derived exosomes containing miR-223, miR-339 and miR-21 could be transferred into SMCs and inhibit PDGFRβ expression; these exosomal miRNAs may be a biomarker for predicting atherothrombosis.

[1]  M. Bennett,et al.  Ageing induced vascular smooth muscle cell senescence in atherosclerosis , 2016, The Journal of physiology.

[2]  R. Schnabel,et al.  miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease , 2015, PloS one.

[3]  P. Libby,et al.  Requiem for the 'vulnerable plaque'. , 2015, European heart journal.

[4]  L. Shaw,et al.  Plaque Characterization by Coronary Computed Tomography Angiography and the Likelihood of Acute Coronary Events in Mid-Term Follow-Up. , 2015, Journal of the American College of Cardiology.

[5]  Shenming Wang,et al.  An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis. , 2015, Journal of the American College of Cardiology.

[6]  P. Zimmermann,et al.  Heparanase activates the syndecan-syntenin-ALIX exosome pathway , 2015, Cell Research.

[7]  V. Fuster,et al.  The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. , 2015, Journal of the American College of Cardiology.

[8]  Athanasios Fevgas,et al.  DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions , 2014, Nucleic Acids Res..

[9]  O. Alfieri,et al.  Exploring unknowns in cardiology , 2014, Nature Reviews Cardiology.

[10]  G. Nickenig,et al.  MicroRNA Expression in Circulating Microvesicles Predicts Cardiovascular Events in Patients With Coronary Artery Disease , 2014, Journal of the American Heart Association.

[11]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[12]  J. Weitz.  Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome , 2014, Thrombosis and Haemostasis.

[13]  S. Mornet,et al.  Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration , 2014, Journal of thrombosis and haemostasis : JTH.

[14]  T. Nyman,et al.  Isolation and characterization of platelet-derived extracellular vesicles , 2014, Journal of extracellular vesicles.

[15]  P. Provost,et al.  Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. , 2013, Blood.

[16]  I. Haviv,et al.  A Novel Mouse Model of Atherosclerotic Plaque Instability for Drug Testing and Mechanistic/Therapeutic Discoveries Using Gene and MicroRNA Expression Profiling , 2013, Circulation research.

[17]  R. Silverman-Gavrila,et al.  Cell division fidelity is altered during the vascular response to injury: its novel role in atherosclerosis progression. , 2013, The American journal of pathology.

[18]  Hugh S Markus,et al.  Circulating MicroRNAs as Novel Biomarkers for Platelet Activation , 2013, Circulation research.

[19]  M. Mayr,et al.  Prospective study on circulating MicroRNAs and risk of myocardial infarction. , 2012, Journal of the American College of Cardiology.

[20]  T. Thum,et al.  MicroRNAs in platelet biogenesis and function , 2012, Thrombosis and Haemostasis.

[21]  Marc P. Bonaca,et al.  Vorapaxar in the secondary prevention of atherothrombotic events. , 2012, The New England journal of medicine.

[22]  G. Owens,et al.  Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. , 2012, Annual review of physiology.

[23]  Paul Burton,et al.  Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.

[24]  Abdimajid Osman,et al.  Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes , 2011, Platelets.

[25]  B. Liu,et al.  Acetylbritannilactone induces G1 arrest and apoptosis in vascular smooth muscle cells. , 2011, International journal of cardiology.

[26]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[27]  L. Edelstein,et al.  MicroRNAs in platelet production and activation. , 2010, Blood.

[28]  G. Rousseau,et al.  Existence of a microRNA pathway in anucleate platelets , 2009, Nature Structural &Molecular Biology.

[29]  S. Ylä-Herttuala,et al.  PDGF‐C and ‐D and their receptors PDGFR‐α and PDGFR‐β in atherosclerotic human arteries , 2009, European Journal of Clinical Investigation.

[30]  C. Caro.  Discovery of the Role of Wall Shear in Atherosclerosis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[31]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[32]  M. Janiszewski,et al.  Platelet-derived exosomes induce endothelial cell apoptosis through peroxynitrite generation: experimental evidence for a novel mechanism of septic vascular dysfunction , 2007, Critical care.

[33]  M. Blaustein,et al.  Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies , 2007, Nature Protocols.

[34]  T. Littlewood,et al.  Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis , 2006, Nature Medicine.

[35]  X. Cheng,et al.  A Simple Method of Plaque Rupture Induction in Apolipoprotein E–Deficient Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[36]  P. Serruys,et al.  The role of shear stress in the destabilization of vulnerable plaques and related therapeutic implications , 2005, Nature Clinical Practice Cardiovascular Medicine.

[37]  R. D. de Winter,et al.  Plaque Instability Frequently Occurs Days or Weeks Before Occlusive Coronary Thrombosis: A Pathological Thrombectomy Study in Primary Percutaneous Coronary Intervention , 2005, Circulation.

[38]  R. Pakala.  Serotonin and thromboxane A2 stimulate platelet-derived microparticle-induced smooth muscle cell proliferation. , 2004, Cardiovascular radiation medicine.

[39]  J. Li,et al.  Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras. , 1999, American journal of respiratory cell and molecular biology.

[40]  B. Lüderitz,et al.  Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. , 1999, Cardiovascular research.

[41]  W. Bode,et al.  Inflammation, sepsis, and coagulation. , 1999, Haematologica.

[42]  C. Leslie,et al.  The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. , 1997, The Journal of clinical investigation.

[43]  S. George,et al.  Proliferation, migration, matrix turnover, and death of smooth muscle cells in native coronary and vein graft atherosclerosis. , 1996, Current opinion in cardiology.

[44]  V. Fuster,et al.  Effect of an Eccentric Severe Stenosis on Fibrin(ogen) Deposition on Severely Damaged Vessel Wall in Arterial Thrombosis: Relative Contribution of Fibrin(ogen) and Platelets , 1994, Circulation.

[45]  A. Beaudoin,et al.  Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. , 1993, The American journal of physiology.

[46]  R. Ross,et al.  A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. , 1974, Proceedings of the National Academy of Sciences of the United States of America.